Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31157964

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2019 Jul 11
First author
Davis ID

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2019 Aug;9(8):OF7. doi: 10.1158/2159-8290.CD-NB2019-066.
    note
    Source null
    related pmid
    31164340
    relationship
    Comment in
  2. citation
    N Engl J Med. 2019 Jul 11;381(2):176-177. doi: 10.1056/NEJMe1906363.
    note
    Source null
    related pmid
    31291522
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2019 Oct;16(10):597-598. doi: 10.1038/s41571-019-0254-9.
    note
    Source null
    related pmid
    31312041
    relationship
    Comment in
  4. citation
    Eur Urol. 2019 Dec;76(6):872-873. doi: 10.1016/j.eururo.2019.07.018.
    note
    Source null
    related pmid
    31352977
    relationship
    Comment in
  5. citation
    Eur Urol. 2020 Feb;77(2):286-287. doi: 10.1016/j.eururo.2019.08.033.
    note
    Source null
    related pmid
    31522916
    relationship
    Comment in
  6. citation
    Eur Urol. 2020 Jan;77(1):132-133. doi: 10.1016/j.eururo.2019.08.029.
    note
    Source null
    related pmid
    31542306
    relationship
    Comment in
  7. citation
    N Engl J Med. 2019 Oct 10;381(15):1493. doi: 10.1056/NEJMc1910553.
    note
    Source null
    related pmid
    31597030
    relationship
    Comment in
  8. citation
    N Engl J Med. 2019 Oct 10;381(15):1493-1494. doi: 10.1056/NEJMc1910553.
    note
    Source null
    related pmid
    31597031
    relationship
    Comment in
  9. citation
    N Engl J Med. 2019 Oct 10;381(15):1494. doi: 10.1056/NEJMc1910553.
    note
    Source null
    related pmid
    31597032
    relationship
    Comment in
  10. citation
    J Urol. 2020 Jan;203(1):32-33. doi: 10.1097/01.JU.0000611504.41578.ee.
    note
    Source null
    related pmid
    31634064
    relationship
    Comment in
  11. citation
    Aktuelle Urol. 2020 Feb;51(1):10-12. doi: 10.1055/a-0962-6453.
    note
    Source null
    related pmid
    32018325
    relationship
    Comment in

Authors and identifiers

  1. name
    Davis ID
    type
    Author
  2. name
    Martin AJ
    type
    Author
  3. name
    Stockler MR
    type
    Author
  4. name
    Begbie S
    type
    Author
  5. name
    Chi KN
    type
    Author
  6. name
    Chowdhury S
    type
    Author
  7. name
    Coskinas X
    type
    Author
  8. name
    Frydenberg M
    type
    Author
  9. name
    Hague WE
    type
    Author
  10. name
    Horvath LG
    type
    Author
  11. name
    Joshua AM
    type
    Author
  12. name
    Lawrence NJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Davis ID
    type
    Author
  2. name
    Martin AJ
    type
    Author
  3. name
    Stockler MR
    type
    Author
  4. name
    Begbie S
    type
    Author
  5. name
    Chi KN
    type
    Author
  6. name
    Chowdhury S
    type
    Author
  7. name
    Coskinas X
    type
    Author
  8. name
    Frydenberg M
    type
    Author
  9. name
    Hague WE
    type
    Author
  10. name
    Horvath LG
    type
    Author
  11. name
    Joshua AM
    type
    Author
  12. name
    Lawrence NJ
    type
    Author
bibliography ids
  1. nci-bib-851ade6808d858d3d2a0e1cb
book metadata
content sha256
6c4c1c5d82475091734f158ff0f36cfa7775963de68ce76cdc74ff12da5bb95c
document type
citation
dois
  1. 10.1056/NEJMoa1903835
electronic publication date
display
2019 Jun 2
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31157964
immutable id
pubmed:31157964@6c4c1c5d82475091734f158ff0f36cfa7775963de68ce76cdc74ff12da5bb95c
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
2
name
The New England journal of medicine
nlm unique id
0255562
pages
121-131
volume
381
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2019 Aug;9(8):OF7. doi: 10.1158/2159-8290.CD-NB2019-066.
    note
    Source null
    related pmid
    31164340
    relationship
    Comment in
  2. citation
    N Engl J Med. 2019 Jul 11;381(2):176-177. doi: 10.1056/NEJMe1906363.
    note
    Source null
    related pmid
    31291522
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2019 Oct;16(10):597-598. doi: 10.1038/s41571-019-0254-9.
    note
    Source null
    related pmid
    31312041
    relationship
    Comment in
  4. citation
    Eur Urol. 2019 Dec;76(6):872-873. doi: 10.1016/j.eururo.2019.07.018.
    note
    Source null
    related pmid
    31352977
    relationship
    Comment in
  5. citation
    Eur Urol. 2020 Feb;77(2):286-287. doi: 10.1016/j.eururo.2019.08.033.
    note
    Source null
    related pmid
    31522916
    relationship
    Comment in
  6. citation
    Eur Urol. 2020 Jan;77(1):132-133. doi: 10.1016/j.eururo.2019.08.029.
    note
    Source null
    related pmid
    31542306
    relationship
    Comment in
  7. citation
    N Engl J Med. 2019 Oct 10;381(15):1493. doi: 10.1056/NEJMc1910553.
    note
    Source null
    related pmid
    31597030
    relationship
    Comment in
  8. citation
    N Engl J Med. 2019 Oct 10;381(15):1493-1494. doi: 10.1056/NEJMc1910553.
    note
    Source null
    related pmid
    31597031
    relationship
    Comment in
  9. citation
    N Engl J Med. 2019 Oct 10;381(15):1494. doi: 10.1056/NEJMc1910553.
    note
    Source null
    related pmid
    31597032
    relationship
    Comment in
  10. citation
    J Urol. 2020 Jan;203(1):32-33. doi: 10.1097/01.JU.0000611504.41578.ee.
    note
    Source null
    related pmid
    31634064
    relationship
    Comment in
  11. citation
    Aktuelle Urol. 2020 Feb;51(1):10-12. doi: 10.1055/a-0962-6453.
    note
    Source null
    related pmid
    32018325
    relationship
    Comment in
outcomes validated
false
pmid
31157964
provenance
batch id
23ffe1e2a9e160b6dca0
provider
NCBI PubMed ESummary
record sha256
5fe0ef748eeee0f316a37a73a8117935bf85d80f76d37fe03b660a386fdd741d
response sha256
d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
retrieved at
2026-09-09T23:47:44.690737+00:00
publication date
display
2019 Jul 11
precision
day
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31157964/
title
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.

Preserved source evidence · Not medical advice